Skip to main content
. 2020 Apr 16;20:73. doi: 10.1186/s12905-020-00939-1

Table 5.

Total score and single items of FSFI-6 in:: a) CSII and MDI-treated women vs Control group; b) in women affected by complicated DM (Complications) or without complications (No complications) vs Control group

Questionnaires CSII MDI Control group P value
Total score 21.5 ± 4.2 18.8 ± 6.6 24.8 ± 3.4 0.0004
ITEM - 1 3.2 ± 0.7 2.9 ± 1.0 4.1 ± 0.7 < 0.0001
ITEM - 2 3.9 ± 0.7 3.2 ± 1.1 4.1 ± 0.9 0.0087
ITEM - 3 3.7 ± 1.4 2.6 ± 1.9 4.5 ± 0.8 0.0014
ITEM - 4 3.5 ± 1.4 3.5 ± 1.5 4.2 ± 0.9 0.1255
ITEM - 5 4.1 ± 0.7 3.1 ± 1.7 4.2 ± 0.7 0.1345
ITEM - 6 3.2 ± 1.0 3.6 ± 1.0 3.6 ± 1.0 0.2386
Questionnaires Complications No complications Control group P value
Total score 18.1 ± 5.9 22.1 ± 4.1 24.8 ± 3.4 < 0.0001
ITEM - 1 2.9 ± 1.0 3.2 ± 0.6 4.1 ± 0.7 < 0.0001
ITEM - 2 3.3 ± 1.1 3.8 ± 0.8 4.1 ± 0.9 < 0.0133
ITEM - 3 2.5 ± 1.6 3.9 ± 1.4 4.5 ± 0.8 < 0.0002
ITEM - 4 3.1 ± 1.5 3.6 ± 1.3 4.2 ± 0.9 < 0.0257
ITEM - 5 3.1 ± 1.5 4.2 ± 0.8 4.2 ± 0.7 < 0.0296
ITEM - 6 3.2 ± 0.9 3.4 ± 1.0 3.6 ± 1.0 0.2458

DM Diabetes Mellitus, MDI Multi Daily Infusion, CSII Continuous Subcutaneous Insulin Infusion, FSFI Female Sexual Function Index